Fever with Thrombocytopenia Syndrome
Conditions
Interventions
Sponsors
Beijing Ditan Hospital, Capital Medical University
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: 1. Inclusion of suspected, clinically diagnosed, and confirmed SFTS cases according to the "diagnosis and treatment Protocol for Severe fever with thrombocytopenia Syndrome (2023 version)"; 2. age >=18 years old, both sexes; 3. Signed informed consent.
Exclusion criteria
Exclusion criteria: 1. Research on the application of SFTSV nucleic acid detection technology based on automatic rapid molecular diagnosis technology: (1) Patients with delayed data collection or missing clinical data due to various reasons; (2) It was not possible to collect samples from patients. 2. Clinical research on the diagnosis and treatment of SFTS based on the TCM and Western medicine synergy strategy: (1) Patients with severe underlying diseases (such as acute myocardial infarction, end-stage heart failure, decompensated liver cirrhosis, chronic renal failure uremic stage); (2) Patients with autoimmune diseases; (3) Severe hematological diseases (immune thrombocytopenic purpura, acute and chronic leukemia); (4) Pregnant and lactating patients.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Case fatality rate;Severe conversion rate; | — |
Secondary
| Measure | Time frame |
|---|---|
| Improvement of important laboratory indicators: Decrease of SFTSV nucleic acid load, recovery time of platelet count, recovery time of liver and kidney function, etc;Length of stay;Potential association between changes in nucleic acid levels and different syndrome types;Incidence of complications; | — |
Countries
China
Contacts
Public ContactZhang Wei
Beijing Ditan Hospital, Capital Medical University
Outcome results
None listed